Last data update: May 06, 2024. (Total: 46732 publications since 2009)
Records 1-6 (of 6 Records) |
Query Trace: Kramarow EA[original query] |
---|
Quickstats: Percentage* of adults aged ≥18 years with diagnosed diabetes,(†) by urbanization level(§) and age group - National Health Interview Survey, United States, 2022(¶)
Kramarow EA , Elgaddal N . MMWR Morb Mortal Wkly Rep 2024 73 (2) 49 In 2022, 9.6% of adults aged ≥18 years had diagnosed diabetes, with the percentage lower among adults living in metropolitan areas (9.2%) compared with adults in nonmetropolitan areas (11.8%). The prevalence of diagnosed diabetes was lower in metropolitan areas only among those aged 35–49 years (5.3% versus 7.7%) and aged 50–64 years (13.3% versus 16.3%). The prevalence of diagnosed diabetes increased with age overall, from 1.3% among adults aged 18–34 years to 20.1% among adults aged ≥65 years, and in both metropolitan and nonmetropolitan areas. |
QuickStats: Sepsis-related* death rates(†) among persons aged ≥ 65 years, by age group and sex - National Vital Statistics System, United States, 2021
Gorina Y , Kramarow EA . MMWR Morb Mortal Wkly Rep 2023 72 (38) 1043 In 2021, the sepsis-related death rate among persons aged ≥65 years was 330.9 deaths per 100,000 population; the rate among men (371.7) was higher than that among women (297.4). Sepsis-related death rates among men were higher than those among women in each age group: 232.7 versus 173.0 (65–74 years), 477.3 versus 349.8 (75–84 years), and 1,037.8 versus 755.5 (≥85 years). Sepsis-related death rates increased with age from 201.1 among persons aged 65–74 years to 858.3 among those aged ≥85 years. Sepsis-related death rates increased with age among both men and women. |
JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023
Owens LE , Currie DW , Kramarow EA , Siddique S , Swanson M , Carter RJ , Kriss JL , Boersma PM , Lee FC , Spicknall I , Hurley E , Zlotorzynska M , Gundlapalli AV . MMWR Morb Mortal Wkly Rep 2023 72 (13) 342-347 From May 2022 through the end of January 2023, approximately 30,000 cases of monkeypox (mpox) have been reported in the United States and >86,000 cases reported internationally.* JYNNEOS (Modified Vaccinia Ankara vaccine, Bavarian Nordic) is recommended for subcutaneous administration to persons at increased risk for mpox (1,2) and has been demonstrated to provide protection against infection (3-5). To increase the total number of vaccine doses available, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) on August 9, 2022, recommending administration of the vaccine intradermally (0.1 mL per dose) for persons aged ≥18 years who are recommended to receive it (6); intradermal administration can generate an equivalent immune response to that achieved through subcutaneous injection using approximately one fifth the subcutaneous dose (7). CDC analyzed JYNNEOS vaccine administration data submitted to CDC from jurisdictional immunization information systems (IIS)(†) to assess the impact of the EUA and to estimate vaccination coverage among the population at risk for mpox. During May 22, 2022-January 31, 2023, a total of 1,189,651 JYNNEOS doses (734,510 first doses and 452,884 second doses)(§) were administered. Through the week of August 20, 2022, the predominant route of administration was subcutaneous, after which intradermal administration became predominant, in accordance with FDA guidance. As of January 31, 2023, 1-dose and 2-dose (full vaccination) coverage among persons at risk for mpox is estimated to have reached 36.7% and 22.7%, respectively. Despite a steady decline in mpox cases from a 7-day daily average of more than 400 cases on August 1, 2022, to five cases on January 31, 2023, vaccination for persons at risk for mpox continues to be recommended (1). Targeted outreach and continued access to and availability of mpox vaccines to persons at risk are important to help prevent and minimize the impact of a resurgence of mpox. |
Veteran status, sociodemographic characteristics, and healthcare factors associated with visiting a mental health professional
Frenk SM , Sautter JM , Woodring JV , Kramarow EA . Community Ment Health J 2016 53 (5) 515-524 Using data from a nationally representative study of the community-dwelling U.S. population, we estimated the percentage of male veterans who visited a mental health professional in the past year, compared it to an estimate from non-veteran males, and examined factors associated with visiting a mental health professional. We found that 10.5% of male veterans visited a mental health professional in the past year, compared to only 5.6% of male non-veterans. In the regression models, veteran status, sociodemographic factors, and healthcare utilization were independently associated with visiting a mental health professional. These findings demonstrate the importance of using nationally representative data to assess the mental healthcare needs of veterans. |
The health of male veterans and nonveterans aged 25-64: United States, 2007-2010
Kramarow EA , Pastor PN . NCHS Data Brief 2012 (101) 1-8 The well-being of military personnel and their families is a topic of growing concern in public health. The effects of military service on physical and psychological health, especially after extended overseas deployments, are complex. There may also be long-term consequences of military service for the health and health care utilization of veterans as they age. Today, over 12 million men aged 25-64 in the United States are veterans, representing 15% of the total U.S. male population at those ages. More attention is now being paid to gathering accurate data to help veterans readjust to civilian life (3). Many studies of veterans only use information from military or veteran databases, which limits the ability to make comparisons with the overall population. This report uses data from the 2007-2010 National Health Interview Survey (NHIS) to describe the health status of community-dwelling male veterans aged 25-64. It directly compares the health status of veterans with nonveterans on a variety of measures. |
Identifying chronic conditions in Medicare claims data: evaluating the Chronic Condition Data Warehouse algorithm
Gorina Y , Kramarow EA . Health Serv Res 2011 46 (5) 1610-27 OBJECTIVE: To examine the strengths and limitations of the Center for Medicare and Medicaid Services' Chronic Condition Data Warehouse (CCW) algorithm for identifying chronic conditions in older persons from Medicare beneficiary data. DATA SOURCES: Records from participants of the NHANES I Epidemiologic Follow-up Study (NHEFS 1971-1992) linked to Medicare claims data from 1991 to 2000. STUDY DESIGN: We estimated the percent of preexisting cases of chronic conditions correctly identified by the CCW algorithm during its reference period and the number of years of claims data necessary to find a preexisting condition. PRINCIPAL FINDINGS: The CCW algorithm identified 69 percent of preexisting diabetes cases but only 17 percent of preexisting arthritis cases. Cases identified by the CCW are a mix of preexisting and newly diagnosed conditions. CONCLUSIONS: The prevalence of conditions needing less frequent health care utilization (e.g., arthritis) may be underestimated by the CCW algorithm. The CCW reference periods may not be sufficient for all analytic purposes. |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure